NCT07403630 2026-02-17IT-TCP POSAzienda Ospedaliero-Universitaria di ParmaPhase NA Recruiting300 enrolled
NCT00112827 2025-06-06Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple MyelomaCity of Hope Medical CenterPhase 1/2 Completed54 enrolled 13 charts
NCT00792142 2021-08-19Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple MyelomaCity of Hope Medical CenterPhase 2 Completed45 enrolled 8 charts
NCT00049504 2017-05-17Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled 10 charts
NCT00217438 2015-08-21Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple MyelomaFred Hutchinson Cancer CenterPhase 3 Completed130 enrolled 6 charts
NCT00361049 2010-11-05Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantCase Comprehensive Cancer CenterPhase 1 Completed49 enrolled